Unraveling the safety and efficacy of semaglutide for people living with HIV and metabolic co-morbidities

Dimitrios Patoulias; Paschalis Karakasis; Ieva Ruža; Mohamed El-Tanani; Manfredi Rizzo

doi:10.1080/14740338.2024.2435426

Unraveling the safety and efficacy of semaglutide for people living with HIV and metabolic co-morbidities

Dimitrios Patoulias
, Paschalis Karakasis
, Ieva Ruža
, Mohamed El-Tanani
, Manfredi Rizzo

University of Thessaloniki
Riga East University Hospital
University of Palermo

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	121-124
Number of pages	4
Journal	Expert Opinion on Drug Safety
Volume	24
Issue number	2
DOIs	https://doi.org/10.1080/14740338.2024.2435426
State	Published - 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

HIV
cardiovascular disease
dysmetabolism
obesity
semaglutide

Access to Document

10.1080/14740338.2024.2435426

Cite this

@article{e93b1ec96a2b44449e9482f8b6b8aa66,

title = "Unraveling the safety and efficacy of semaglutide for people living with HIV and metabolic co-morbidities",

keywords = "HIV, cardiovascular disease, dysmetabolism, obesity, semaglutide",

author = "Dimitrios Patoulias and Paschalis Karakasis and Ieva Ru{\v z}a and Mohamed El-Tanani and Manfredi Rizzo",

year = "2025",

doi = "10.1080/14740338.2024.2435426",

language = "English",

volume = "24",

pages = "121--124",

journal = "Expert Opinion on Drug Safety",

issn = "1474-0338",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

TY - JOUR

T1 - Unraveling the safety and efficacy of semaglutide for people living with HIV and metabolic co-morbidities

AU - Patoulias, Dimitrios

AU - Karakasis, Paschalis

AU - Ruža, Ieva

AU - El-Tanani, Mohamed

AU - Rizzo, Manfredi

PY - 2025

Y1 - 2025

KW - HIV

KW - cardiovascular disease

KW - dysmetabolism

KW - obesity

KW - semaglutide

UR - https://www.scopus.com/pages/publications/85210742494

U2 - 10.1080/14740338.2024.2435426

DO - 10.1080/14740338.2024.2435426

M3 - Editorial

C2 - 39610149

AN - SCOPUS:85210742494

SN - 1474-0338

VL - 24

SP - 121

EP - 124

JO - Expert Opinion on Drug Safety

JF - Expert Opinion on Drug Safety

IS - 2

ER -

Unraveling the safety and efficacy of semaglutide for people living with HIV and metabolic co-morbidities

UN SDGs

Keywords

Access to Document

Other files and links

Cite this